Viking Therapeutics

VKTX Mid Cap

Healthcare · Biotechnology

Aktualisiert: Apr 5, 2026, 17:43 UTC

$34.80

+5.58% heute

52W: $18.92 – $43.15

52W Low: $18.92 Position: 65.5% 52W High: $43.15

🔗 Broker vergleichen

Kennzahlen

P/E Ratio

—

Kurs/Gewinn-Verhältnis

Forward P/E

—

Erwartetes KGV

P/S Ratio

—

Kurs/Umsatz-Verhältnis

EV/EBITDA

—

Unternehmenswert/EBITDA

Dividendenrendite

—

Jährl. Dividendenrendite

Market Cap

$4B

Marktkapitalisierung

Umsatzwachstum

—

YoY Umsatzwachstum

Gewinnmarge

—

Nettomarge

ROE

-47.34%

Eigenkapitalrendite

Beta

0.82

Marktsensitivität

Short Interest

25.09%

% der Aktien leerverkauft

Ø Volumen

2,959,552

Durchschn. Tagesvolumen

Bewertungs-Analyse

Signal

N/A

vs. S&P 500 Ø KGV (24.7x)

Analysten-Konsens

Starker Kauf

18 Analysten

Ø Kursziel

$92.72

+166.44% Upside

Kursziel Spanne

$35.00 – $125.00

Über das Unternehmen

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, which is in Phase II clinical trials for metabolic disorders and anemia; VK2735, a novel dual agonist of the glucagon-like peptide 1, which is in

Sektor: Healthcare Branche: Biotechnology Land: United States Mitarbeiter: 53 Börse: NCM

Trading-Daten

50-Day MA: $32.06

200-Day MA: $32.22

Volumen: 3,586,008

Ø Volumen: 2,959,552

Short Ratio: 9.62

Kurs/Buchwert: 6.25x

Verschuldung/EK: 0.02x

Free Cash Flow: $-160,217,744

Wo kann ich Viking Therapeutics kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.

Broker vergleichen →